Skip to main content
Joyce Teng, MD, Dermatology, Palo Alto, CA, Lucile Packard Children's Hospital Stanford

JoyceMTengMDPhD

Dermatology Palo Alto, CA

Pediatric Dermatology

Associate Professor, Dermatology, Stanford University

Dr. Teng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Teng's full profile

Already have an account?

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Dermatology, 2005 - 2006
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Dermatology, 2002 - 2005
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterInternship, Transitional Year, 2001 - 2002
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2001
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center1994 - 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2024
  • WI State Medical License
    WI State Medical License 2006 - 2013
  • CO State Medical License
    CO State Medical License 2005 - 2007
  • American Board of Dermatology Dermatology
  • American Board of Dermatology Pediatric Dermatology

Awards, Honors, & Recognition

  • Member Women's Dermatologic Society
  • Member Society of Pediatric Dermatology
  • Member Dermatology Foundation
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • FDA Expands Approval of Two Plaque Psoriasis Therapies to Include Younger Patients
    FDA Expands Approval of Two Plaque Psoriasis Therapies to Include Younger PatientsAugust 1st, 2019
  • LEO Pharma Inc. Announces U.S. Food and Drug Administration (FDA) Expanded
    LEO Pharma Inc. Announces U.S. Food and Drug Administration (FDA) ExpandedJuly 31st, 2019
  • Sirolimus Add-on Seen Helpful for Visible Arteriovenous Malformations
    Sirolimus Add-on Seen Helpful for Visible Arteriovenous MalformationsSeptember 20th, 2018
  • Join now to see all

Professional Memberships

Other Languages

  • Chinese (Mandarin)

Hospital Affiliations